NASDAQ: CAPR · Biotechnology
Over the past week, Capricor Therapeutics (CAPR) drew about 119 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 42% bullish but is deeply split: Reddit runs 50% bullish while News sits at just 28%. Wall Street is roughly in line with the crowd, with 4 of 10 analysts rating CAPR a buy.
There is little buzz around CAPR this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 40% buy share sits next to a crowd that ranges from News at 28% to Reddit at 50%. No other tracker puts the two side by side.
Across 10 analysts the consensus is a Hold: 4 buy calls against 0 sell, with an average 12-month price target of $27.00.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is improving and the 3 sources only partly agree, so the read is a Sell.
Wall Street’s 40% buy share lands almost exactly on the crowd average of 42%. The split is inside the crowd: Reddit reads 50% bullish while News sits at 28%, a 22-point spread that single-source trackers miss.
Over the 30-day window, Capricor Therapeutics (CAPR) buzz held subdued around 20.1 while the price drifted down 6.5% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 3.7M shares. Updated Oct 10, 2026. Over the last 7 trading days, CAPR lost 12.4%. Buzz activity in the recent week averaged 37.1 and was variable, swinging between 20.1 and 44.8. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 11 of the 20 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for CAPR and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live CAPR sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 10, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Hold (4 / 6 / 0) |
| Crowd bullish (7d) | 42% |
| Avg price target | $27.00 |
| Most bullish source | Reddit, 50% |
| Most bearish source | News, 28% |
| Sentiment spread | 22 pts |
| Mentions (7d) | 119 |
| Market cap | $465.7M |
| P/E · Forward P/E | n/a · 78.7 |
| EPS · Beta | -$2.45 · 0.6 |
| Revenue (TTM) | $11.1M · 0% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Capricor Therapeutics (CAPR) currently carries an Adanos sell signal with 88/100 conviction. The current cross-source average reads 42% bullish across 3 active sources. Those sources contribute 119 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Capricor Therapeutics (CAPR) is fairly quiet with 6 mentions over the last 7 days; the 30-day context spans 8 tracked subreddits. The 7-day tone is 50% bullish; 3-day activity momentum is rising, suggesting building attention.
The crowd reads bearish on Capricor Therapeutics (CAPR), averaging 42% bullish across 3 tracked sources over the last 7 days. The two ends of the range are Reddit at 50% bullish and News at 28%, a 22-point spread. On the professional side, 4 of 10 analysts rate CAPR a buy.
Of the 10 analysts covering Capricor Therapeutics (CAPR), 4 rate it a buy, 6 a hold and 0 a sell, for a hold consensus. The average price target is $27.00. That lines up with the crowd average of 42% bullish.
Capricor Therapeutics (CAPR)'s cross-source average is bearish at 42% bullish. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish. Reddit reads 50% bullish, X reads 49% bullish and news coverage is the most negative at 28% bullish. The combined signal points to broad sell-side pressure with 88/100 conviction.
The cross-source average is bearish for Capricor Therapeutics (CAPR) at 42% bullish. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish. The most bearish reading is news at 28% bullish. 3-day activity momentum is falling on X, while reddit and news activity is rising. The sell signal carries 88/100 conviction.
X is the dominant discussion channel with 106 mentions (89% of total volume). News contributes 7 mentions and Reddit contributes 6 mentions. The cross-source average is bearish at 42% bullish, while reddit and news show rising 3-day activity. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. CAPR's sell signal at 88/100 conviction reflects a bearish cross-source average at 42% bullish. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish. It is a research shortcut, not financial advice.
The CAPR sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key